Emcure Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2024.

Emcure Pharmaceuticals has posted net profit of Rs. 194.57 crores for the period ended September 30, 2024 as against net profit of Rs. 144.08 crores for the period ended June 30, 2024.  The company posted net profit of Rs. 139.15 crores for the period ended September 30, 2023.

Emcure Pharmaceuticals has reported total income of Rs. 2,037.63 crores during the period ended September 30, 2024 as compared to Rs. 1,838.579 crores during the period ended June 30, 2024. The company reported total income of Rs. 1,664.423 crores during the period ended September 30, 2023.

For the Financial Year ended Sept 2024, Emcure Pharmaceuticals has reported total income of Rs. 3,876.21 crores during the 6 months period ended September 30, 2024 as compared to Rs. 3,235.56 crores during the 6 months period ended September 30, 2023.

The company has posted net profit of Rs. 338.65 crores for the 6 months period ended September 30, 2024 as against net profit of Rs. 269.56 crores for the 6 months period ended September 30, 2023.